Study reveals dual role of PFK enzyme in metabolism and cell cycle progression

Hidden Enzyme Function Rewrites Cell Biology Textbooks

For over seven decades, phosphofructokinase (PFK) has been a cornerstone of biochemistry, understood solely for its role in glycolysis – the process cells leverage to break down sugar for energy. Now, a groundbreaking study led by the University of Surrey has revealed a stunning second life for this enzyme, one that controls cell division. This discovery, published in Nucleic Acids Research, isn’t just a tweak to existing knowledge; it’s a potential paradigm shift in how we understand cellular regulation.

PFK: From Energy Production to Cell Cycle Control

PFK, specifically its Pfk2 subunit, isn’t just a metabolic gatekeeper. Researchers found it actively unwinds RNA and promotes the translation of genes essential for cell division. This means Pfk2 binds to messenger RNA (mRNA), unravels short double-stranded sections, and boosts the production of proteins that drive cells to divide. The team demonstrated this by observing that yeast cells lacking Pfk2 grew slower, became larger, and struggled to progress through the critical G1 to S phase of the cell cycle – the point of no return for cell division.

A Molecular Relay Switch: Linking Metabolism to Growth

The research suggests a fascinating “molecular relay switch” model. When energy levels are low, PFK prioritizes glycolysis. But when energy is plentiful, Pfk2 shifts gears, focusing on RNA regulation and promoting cell division. This creates a direct link between a cell’s energy status and its decision to grow and proliferate. This isn’t just theoretical; reintroducing a version of Pfk2 unable to perform glycolysis still rescued the cell division defects, proving the two functions are independent.

Beyond Yeast: Implications for Human Health

While the initial discovery was made in Saccharomyces cerevisiae (baker’s yeast), the implications for human health are significant. Misregulation of the cell cycle is a hallmark of cancer, and understanding how fundamental enzymes like PFK control this process could open novel avenues for therapeutic intervention. The study identified over 800 mRNAs that Pfk2 binds, many coding for proteins directly involved in the mitotic cell cycle.

New Avenues for Cancer Research and Therapeutics

The discovery of Pfk2’s dual role could lead to the development of novel cancer therapies. Targeting this enzyme, or the specific RNA interactions it mediates, might offer a way to selectively disrupt the uncontrolled cell division characteristic of tumors. Professor André Gerber of the University of Surrey emphasized that this discovery opens up new avenues to advance our knowledge of critical cell functions.

The Future of Enzyme Research: What Else is Hidden?

This finding challenges the long-held assumption that enzymes have single, defined functions. It begs the question: how many other enzymes possess hidden capabilities waiting to be uncovered? The research team employed a combination of RNA sequencing, biochemical assays, and proteomics to reach their conclusions, highlighting the power of modern analytical techniques in revealing previously unknown biological mechanisms.

Did you recognize? PFK has been a subject of intensive study since the 1950s, yet this crucial second function remained hidden for decades.

FAQ

• What is phosphofructokinase (PFK)? PFK is an enzyme central to glycolysis, the process of breaking down sugar for energy.
• What is the newly discovered function of Pfk2? Pfk2 can unwind RNA and promote cell division.
• Why is this discovery important? It challenges the traditional understanding of enzyme function and could lead to new cancer therapies.
• In what organism was this discovery made? The initial discovery was made in the yeast Saccharomyces cerevisiae.

Pro Tip: Understanding the interplay between metabolism and cell cycle regulation is crucial for developing effective strategies to combat diseases like cancer.

Want to learn more about cellular processes and cutting-edge research? Explore our other articles on molecular biology and cancer research.

Stay updated with the latest scientific breakthroughs! Subscribe to our newsletter for regular insights and updates.